Healthcare -
Biotechnology - NASDAQ - US
$ 19.07
-7.43 %
$ 3.24 B
Market Cap
-7.28
P/E
IMVT - OPERATING INCOME
Operating Income IMVT - Immunovant, Inc.
-283 M
LAST VALUE
-34.55%
2 YEAR CAGR
-1344.19%
5 YEAR CAGR
0.00%
10 YEAR CAGR